Paul Hachem

414 total citations
20 papers, 331 citations indexed

About

Paul Hachem is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Paul Hachem has authored 20 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Paul Hachem's work include Cancer-related Molecular Pathways (9 papers), Prostate Cancer Treatment and Research (8 papers) and Cell death mechanisms and regulation (4 papers). Paul Hachem is often cited by papers focused on Cancer-related Molecular Pathways (9 papers), Prostate Cancer Treatment and Research (8 papers) and Cell death mechanisms and regulation (4 papers). Paul Hachem collaborates with scholars based in United States, France and Australia. Paul Hachem's co-authors include Alan Pollack, Zhaomei Mu, Sudhir Agrawal, Marvin L. Meistrich, Radka Stoyanova, Alexandra L. Hanlon, Andrew C. von Eschenbach, Faramarz Ashoori, Alan Pollack and Daryl Lim Joon and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, International Journal of Cancer and Physics in Medicine and Biology.

In The Last Decade

Paul Hachem

20 papers receiving 323 citations

Peers

Paul Hachem

PRM

ONCOL

RNMI

Prabir Chakravarty United States

Blaž Grošelj Slovenia

Grete Hasvold Norway

Svetlana Gourevitch Israel

Jing Jin China

Diane Heiser United States

Jennifer Shah United States

Franziska Niehr Germany

B. Bibby United Kingdom

F. R. Hirsch United States

Prabir Chakravarty United States

Paul Hachem

53 ×0.3

PRM

98 ×0.7

216 ×1.9

ONCOL

34 ×0.6

51 ×1.1

RNMI

Citations per year, relative to Paul Hachem Paul Hachem (= 1×) peers Prabir Chakravarty

Countries citing papers authored by Paul Hachem

Since Specialization

Citations

This map shows the geographic impact of Paul Hachem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Hachem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Hachem more than expected).

Fields of papers citing papers by Paul Hachem

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Hachem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Hachem. The network helps show where Paul Hachem may publish in the future.

Co-authorship network of co-authors of Paul Hachem

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Hachem. A scholar is included among the top collaborators of Paul Hachem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Hachem. Paul Hachem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Udayakumar, Thirupandiyur S., et al.. (2011). Adenovirus E2F1 Overexpression Sensitizes LNCaP and PC3 Prostate Tumor Cells to Radiation In Vivo. International Journal of Radiation Oncology*Biology*Physics. 79(2). 549–558. 12 indexed citations

Hensley, Harvey H., Jean‐Michel Hannoun‐Lévi, Paul Hachem, et al.. (2010). PKA knockdown enhances cell killing in response to radiation and androgen deprivation. International Journal of Cancer. 128(4). 962–973. 17 indexed citations

Chen, Lili, et al.. (2010). MR-guided focused ultrasound: enhancement of intratumoral uptake of [³H]-docetaxelin vivo. Physics in Medicine and Biology. 55(24). 7399–7410. 18 indexed citations

Mu, Zhaomei, Paul Hachem, Harvey H. Hensley, et al.. (2008). Antisense MDM2 enhances the response of androgen insensitive human prostate cancer cells to androgen deprivation in vitro and in vivo. The Prostate. 68(6). 599–609. 21 indexed citations

Udayakumar, Thirupandiyur S., Paul Hachem, Mansoor M. Ahmed, Sudhir Agrawal, & Alan Pollack. (2008). Antisense MDM2 Enhances E2F1-Induced Apoptosis and the Combination Sensitizes Androgen-Dependent and Androgen-Independent Prostate Cancer Cells to Radiation. Molecular Cancer Research. 6(11). 1742–1754. 12 indexed citations

Stoyanova, Radka, Paul Hachem, Harvey H. Hensley, et al.. (2007). Antisense-MDM2 Sensitizes LNCaP Prostate Cancer Cells to Androgen Deprivation, Radiation, and the Combination In Vivo. International Journal of Radiation Oncology*Biology*Physics. 68(4). 1151–1160. 26 indexed citations

Hachem, Paul, Arik Hananel, Zhaomei Mu, et al.. (2007). TH-C-M100J-09: MR Guided Focused Ultrasound (MRgFU) For The Treatmentment of Prostate Cancer: A Feasibility Study of Increasing Cellular Uptake of AS-MDM2 in Vivo. Medical Physics. 34(6Part22). 2625–2625. 2 indexed citations

Hensley, Harvey H., et al.. (2006). 2198. International Journal of Radiation Oncology*Biology*Physics. 66(3). S319–S320. 1 indexed citations

Hachem, Paul, Li Yan Khor, M. Elizabeth Hammond, et al.. (2006). 2280. International Journal of Radiation Oncology*Biology*Physics. 66(3). S365–S366. 1 indexed citations

10.

Nguyen, Khanh, Paul Hachem, Li‐Yan Khor, et al.. (2005). Adenoviral-E2F-1 radiosensitizes p53wild-type and p53null human prostate cancer cells. International Journal of Radiation Oncology*Biology*Physics. 63(1). 238–246. 17 indexed citations

11.

Mu, Zhaomei, Paul Hachem, & Alan Pollack. (2005). Antisense Bcl-2 sensitizes prostate cancer cells to radiation. The Prostate. 65(4). 331–340. 39 indexed citations

12.

Mu, Zhaomei, Paul Hachem, Sudhir Agrawal, & Alan Pollack. (2004). Antisense MDM2 oligonucleotides restore the apoptotic response of prostate cancer cells to androgen deprivation. The Prostate. 60(3). 187–196. 18 indexed citations

13.

Mu, Zhaomei, Paul Hachem, Sudhir Agrawal, & Alan Pollack. (2004). Antisense MDM2 sensitizes prostate cancer cells to androgen deprivation, radiation, and the combination. International Journal of Radiation Oncology*Biology*Physics. 58(2). 336–343. 29 indexed citations

14.

Mu, Zhaomei, Paul Hachem, & Alan Pollack. (2004). Antisense to Bcl-2 (Genasense™) sensitizes prostate cancer cells to radiation. International Journal of Radiation Oncology*Biology*Physics. 60(1). S176–S177. 1 indexed citations

15.

Mu, Zhaomei, et al.. (2004). Antisense to Bcl-2 (Genasense™) sensitizes prostate cancer cells to radiation. International Journal of Radiation Oncology*Biology*Physics. 60. S176–S177. 1 indexed citations

16.

Hachem, Paul, et al.. (2004). Protein kinase a riα antisense sensitization of radiation and androgen deprivation. International Journal of Radiation Oncology*Biology*Physics. 60(1). S462–S463. 1 indexed citations

17.

Kaminski, Joseph, Alexandra L. Hanlon, Daryl Lim Joon, et al.. (2003). Effect of sequencing of androgen deprivation and radiotherapy on prostate cancer growth. International Journal of Radiation Oncology*Biology*Physics. 57(1). 24–28. 47 indexed citations

18.

Mu, Zhaomei, et al.. (2003). Antisense MDM2 sensitizes prostate cancer cells to androgen deprivation, radiation, and the combination. International Journal of Radiation Oncology*Biology*Physics. 57(2). S256–S257. 4 indexed citations

19.

Mu, Zhaomei, Paul Hachem, Sandeep Agrawal, & Alan Pollack. (2002). Antisense MDM2 oligonucleotides restore the apoptotic response of prostate cancer cells to androgen deprivation. International Journal of Radiation Oncology*Biology*Physics. 54(2). 191–191. 1 indexed citations

20.

Pollack, Alan, et al.. (2001). Lack of prostate cancer radiosensitization by androgen deprivation. International Journal of Radiation Oncology*Biology*Physics. 51(4). 1002–1007. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact